about
Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working groupSertraline treatment does not increase plasma prolactin levels in healthy subjects.Noradrenaline effects on social behaviour, intergroup relations, and moral decisions'It's the way that you look at it'--a cognitive neuropsychological account of SSRI action in depressionm-Chlorophenylpiperazine decreases food intake in a test mealThe effects of chronic administration of hydrocortisone on cognitive function in normal male volunteersSerotonin and social norms: tryptophan depletion impairs social comparison and leads to resource depletion in a multiplayer harvesting game.Mood, eating behaviour and attention.Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.Cognitive mechanisms of diazepam administration: a healthy volunteer model of emotional processing.Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 teslaBrain glutamate in anorexia nervosa: a magnetic resonance spectroscopy case control study at 7 TeslaEffect of a single dose of citalopram on amygdala response to emotional faces.How do antidepressants work? New perspectives for refining future treatment approaches.Vulnerability to depression is associated with a failure to acquire implicit social appraisals.Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individualsA functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depressionPsychopharmacology of 5-HT(1A) receptors.Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.Preliminary evidence that sub-chronic citalopram triggers the re-evaluation of value in intimate partnerships.Unusual interactions of benzodiazepine receptor antagonists.The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.Atenolol reduces plasma melatonin concentration in man.Predictors of mood response to acute tryptophan depletion. A reanalysis.Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor.Lack of effect of tyrosine depletion on mood in recovered depressed women.Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentrationIncreased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment.Classification of depressive disorders.Ethyl beta-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats.5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.Brain serotonin transporter binding in former users of MDMA ('ecstasy').Decision making in young people at familial risk of depression.Neurochemistry of major depression: a study using magnetic resonance spectroscopyHow cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers.Lithium prescribing during pregnancy: a UK primary care database studyAre You Morally Modified?: The Moral Effects of Widely Used Pharmaceuticals.
P50
Q23747515-B0DAF9F0-0BEE-4E8F-AACA-1657329D155CQ26254043-F55649B6-87D3-4DF4-ABFA-2C83B293259CQ26749108-4083EBA0-EA37-42E2-A56D-1AC3ED6A9B44Q26824072-018F1746-AEE2-4FCD-8CDF-51695AB7B52FQ28307494-282B5A60-EFF5-4BA1-833C-9B19CC86AA98Q28373099-22F0CAF3-B629-4565-A60D-49DE7F1C1F14Q28652294-5F8CEADE-F3FF-4F6A-BF2E-540448529A90Q30330269-A889F5AB-8F28-4B70-909D-8ECF959E65D4Q30374052-E3A115DF-7AA1-4CE6-9921-A9BDDE641A55Q30381167-9E6C1567-86B2-4266-9313-7FB427E2A191Q31036476-0AC9575A-2946-484E-A94B-2C144FC4985CQ31146510-05E91DD1-1D7F-412D-8A86-0296D7763C58Q33575164-C1D1E88A-A78F-4E87-B08B-D0F6E5EC3D32Q33619029-AF9EB491-6CD1-4666-804F-2F3A33FCD8C0Q33634416-7F62EC3A-8BF9-494E-846B-DE47D5B66437Q33688119-6CFDD7D1-A523-476B-8FAC-CEC887BB0A99Q33906501-3964E5B2-93B1-4D96-8F37-BF2AD27C5210Q33931379-31D22080-FE9A-44BA-87C8-D049CE63697CQ34016373-AD59A742-ECC4-4D59-801E-AC4388B38618Q34038812-0BAF8721-D58B-4D82-BBF3-A6D0750A6D08Q34111111-A3DBF3A6-1250-4B1F-B59C-FAE1A79B95CFQ34152467-3EB02D69-CE70-40E1-9794-5FED920FE9E9Q34253105-134CF155-338E-4DDF-9CB5-28A730E7942BQ34335586-639AC36A-27B2-48B7-8AF2-52490B92B80CQ34512094-321B6ABD-9468-46BD-ACF5-6AB0EE2A090FQ34528914-78BD5FA2-9572-4E16-AB2E-7C35183DB850Q34544879-6FE2E43E-EF7D-491E-9D96-61FA2F70CBEEQ34554926-79766B2B-273C-48BB-8B75-3837124189F5Q34622219-877D5873-553E-4705-AC22-0A6950FC68ABQ34622516-DDB7B7E6-8BF5-46CF-96B0-92CFB8908AD9Q34641745-FDCB465B-49D8-47A2-8D23-D2BB29F7F080Q34708115-03CC0D4C-F66C-4821-B52A-64695316DACDQ34721207-7D1A41D7-0793-4EC4-A0CB-107070679E9AQ34972448-B50B894D-37B5-4830-99E0-D6BFBABE23F7Q34992950-F30E5289-4B72-4ABA-90BB-4B0E24C4B121Q34996725-BABE8B6C-3EE4-4033-945C-574A6A82169EQ35096538-B9F5E981-48A6-420B-832D-7979DE65646BQ35178035-666D4220-3D61-46A7-A26C-7C98B189845BQ35203233-0948CD37-EEE1-4C4E-A08B-BBE9B4D53776Q35438719-E741A603-3C82-441E-A579-149043993A29
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philip J. Cowen
@ast
Philip J. Cowen
@en
Philip J. Cowen
@es
Philip J. Cowen
@nl
Philip J. Cowen
@sl
type
label
Philip J. Cowen
@ast
Philip J. Cowen
@en
Philip J. Cowen
@es
Philip J. Cowen
@nl
Philip J. Cowen
@sl
altLabel
Philip Cowen
@en
prefLabel
Philip J. Cowen
@ast
Philip J. Cowen
@en
Philip J. Cowen
@es
Philip J. Cowen
@nl
Philip J. Cowen
@sl
P106
P1153
26643348200
P21
P2456
P31
P496
0000-0001-5518-6138